Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICASSO phase II trial of palifosfamide plus doxorubicin versus doxorubicin in unresectable or metastatic soft-tissue sarcoma
2008-004856-57Phase 2Completed
- Sponsor
- Alaunos Therapeutics
- Start
- Mar 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in soft tissue sarcoma (STS) comparing palifosfamide + doxorubicin with doxorubicin (2 arms). Primary endpoint: progression-free survival. Started Mar 2009; status: completed.
02
Drugs
palifosfamidedoxorubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2008-004856-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004856-57.